SPRY vs TTRX: stock comparison and AI forecast
Ars Pharmaceuticals, Inc. (SPRY) and Turn Therapeutics Inc. (TTRX) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
SPRY Ars Pharmaceuticals, Inc.
- Price
- $3.05 -65.5% · 6M
- Market Cap
- $303M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
TTRX Turn Therapeutics Inc.
- Price
- $10.43 +182.7% · 6M
- Market Cap
- $311M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
- NO CURRENT FORECAST
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- SPRY and TTRX have similar market capitalizations ($303M and $311M).
- Over the last six months TTRX returned +182.7% and SPRY -65.5%.
- TTRX carries 23.69 times debt per unit of equity, against 18.94 times for SPRY.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | SPRY | TTRX |
|---|---|---|
| Market Cap | $303M | $311M |
| P/B Ratio | 24.24x | 452.31x |
| EPS | $-1.91 | $-0.32 |
| Book Value/Share | $0.13 | $0.02 |
| Revenue/Share | $1.26 | – |
| FCF/Share | $-1.98 | – |
Profitability & Margins
| Metric | SPRY | TTRX |
|---|---|---|
| ROE | -1721.8% | -1458.0% |
| ROA | -86.3% | -59.0% |
| ROIC | -114.7% | -106.5% |
| Operating Margin | -173.2% | – |
| Net Margin | -172.5% | – |
| EBT Margin | -166.7% | – |
Financial Health
| Metric | SPRY | TTRX |
|---|---|---|
| Current Ratio | 3.48x | 1.19x |
| Quick Ratio | 2.97x | – |
| D/E Ratio | 18.94x | 23.69x |
| Financial Leverage | 19.94x | 24.69x |
| Interest Coverage | -26.4x | -6.9x |
| Working Capital | $151M | $2M |
Cash Flow
| Metric | SPRY | TTRX |
|---|---|---|
| Operating Cash Flow | -$196M | -$5M |
| Free Cash Flow | -$197M | – |
| Capital Spending | -$200K | – |
| FCF/Sales | -157.4% | – |
| CapEx/Sales | 0.2% | – |
Operational Efficiency
| Metric | SPRY | TTRX |
|---|---|---|
| Asset Turnover | 0.50x | – |
| Receivables Turnover | 2.7x | – |
| Fixed Assets Turnover | 59.9x | – |
| Days Sales Outstanding | 137 days | – |
Income Statement
| Metric | SPRY | TTRX |
|---|---|---|
| Total Revenue | $125M | – |
| Operating Income | -$216M | -$9M |
| Net Income | -$215M | -$10M |
| R&D Expense | $15M | $850K |
| SG&A Expense | $284M | – |
Dividend & Shareholder Information
| Metric | SPRY | TTRX |
|---|---|---|
| Shares Outstanding | 99M | 30M |
SPRY vs TTRX: stock comparison and AI forecast
Which is bigger, SPRY or TTRX?
SPRY and TTRX have similar market capitalizations ($303M and $311M).
Which stock performed better over the last six months, SPRY or TTRX?
Over the last six months TTRX returned +182.7% and SPRY -65.5%.
Which one does Intratio's AI model rank higher, SPRY or TTRX?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.